XML 45 R33.htm IDEA: XBRL DOCUMENT v3.22.1

Goodwill and Other Intangible Assets (Tables)

9 Months Ended

Mar. 31, 2022

Goodwill and Other Intangible Assets

Schedule of change in carrying amount of goodwill

​

​	​	​	​	​	​	​	​	​	​
​		BioPharma			Consumer Health			Consolidated
​	​	(In thousands)
Balance as of June 30, 2021	​	$	57,165	​	$	8,637	​	$	65,802
Goodwill impairment	​		(19,453)	​		—	​		(19,453)
Balance as of September 30, 2021	​	​	37,712	​	​	8,637	​	​	46,349
Goodwill impairment	​	​	—	​	​	—	​	​	—
Balance as of December 31, 2021	​	​	37,712	​	​	8,637	​	​	46,349
Goodwill impairment	​	​	(37,712)	​		—	​		(37,712)
Balance as of March 31, 2022	​	$	—	​	$	8,637	​	$	8,637

Schedule of finite lived intangible assets

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

March 31, 2022

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted-

​

​

Gross

​

​

​

​

​

​

​

Net

​

Average

​

​

Carrying

​

Accumulated

​

​

​

​

Carrying

​

Remaining

​

Amount

Amortization

Impairment

Amount

Life (in years)

​

​

(In thousands)

Licensed assets

​

$

3,246

​

$

(1,778)

​

$

(1,468)

​

$

—

​

—

Acquired product technology right

​

45,400

​

(6,864)

​

(3,224)

​

35,312

12.21

Acquired technology right

​

​

30,200

​

​

(1,834)

​

​

—

​

​

28,366

​

16.00

Acquired product distribution rights

​

11,354

​

(3,204)

​

—

​

8,150

7.85

Acquired in-process R&D

​

​

2,600

​

​

—

​

​

—

​

​

2,600

​

Indefinite-lived

Acquired commercial technology

​

​

630

​

​

(630)

​

​

—

​

​

—

​

—

Acquired trade name

​

​

400

​

​

(206)

​

​

(194)

​

​

—

​

—

Acquired customer lists

​

390

​

(390)

​

—

​

—

—

Total

​

$

94,220

​

$

(14,906)

​

$

(4,886)

​

$

74,428

13.21

​

​	​	​	​	​	​	​	​	​	​	​	​
​	​	June 30, 2021
​	​	​	​	​	​	​	​	​	​	​	Weighted-
​	​	Gross		​	​	​	​	​	​	​	Average
​	​	Carrying		​	Accumulated			​	Net Carrying	​	Remaining
​		Amount			Amortization			Amount			Life (in years)
​	​	(In thousands)
Licensed assets	​	$	3,246	​	$	(1,430)	​	$	1,816	​	3.92
Acquired product technology right	​	​	45,400	​	​	(4,160)	​	​	41,240	​	12.88
Acquired technology right	​	​	30,200	​	​	(501)	​	​	29,699	​	16.75
Acquired product distribution rights	​	​	11,354	​	​	(2,073)	​	​	9,281	​	8.57
Acquired in-process R&D	​		2,600	​		—	​		2,600	​	Indefinite-lived
Acquired commercial technology	​	​	630	​	​	(178)	​	​	452	​	0.75
Acquired trade name	​	​	400	​	​	(56)	​	​	344	​	1.75
Acquired customer lists	​	​	390	​	​	(358)	​	​	32	​	0.01
Total	​	$	94,220	​	$	(8,756)	​	$	85,464	​	13.47

​

Schedule of Indefinite lived intangible assets

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

March 31, 2022

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted-

​

​

Gross

​

​

​

​

​

​

​

Net

​

Average

​

​

Carrying

​

Accumulated

​

​

​

​

Carrying

​

Remaining

​

Amount

Amortization

Impairment

Amount

Life (in years)

​

​

(In thousands)

Licensed assets

​

$

3,246

​

$

(1,778)

​

$

(1,468)

​

$

—

​

—

Acquired product technology right

​

45,400

​

(6,864)

​

(3,224)

​

35,312

12.21

Acquired technology right

​

​

30,200

​

​

(1,834)

​

​

—

​

​

28,366

​

16.00

Acquired product distribution rights

​

11,354

​

(3,204)

​

—

​

8,150

7.85

Acquired in-process R&D

​

​

2,600

​

​

—

​

​

—

​

​

2,600

​

Indefinite-lived

Acquired commercial technology

​

​

630

​

​

(630)

​

​

—

​

​

—

​

—

Acquired trade name

​

​

400

​

​

(206)

​

​

(194)

​

​

—

​

—

Acquired customer lists

​

390

​

(390)

​

—

​

—

—

Total

​

$

94,220

​

$

(14,906)

​

$

(4,886)

​

$

74,428

13.21

​

​	​	​	​	​	​	​	​	​	​	​	​
​	​	June 30, 2021
​	​	​	​	​	​	​	​	​	​	​	Weighted-
​	​	Gross		​	​	​	​	​	​	​	Average
​	​	Carrying		​	Accumulated			​	Net Carrying	​	Remaining
​		Amount			Amortization			Amount			Life (in years)
​	​	(In thousands)
Licensed assets	​	$	3,246	​	$	(1,430)	​	$	1,816	​	3.92
Acquired product technology right	​	​	45,400	​	​	(4,160)	​	​	41,240	​	12.88
Acquired technology right	​	​	30,200	​	​	(501)	​	​	29,699	​	16.75
Acquired product distribution rights	​	​	11,354	​	​	(2,073)	​	​	9,281	​	8.57
Acquired in-process R&D	​		2,600	​		—	​		2,600	​	Indefinite-lived
Acquired commercial technology	​	​	630	​	​	(178)	​	​	452	​	0.75
Acquired trade name	​	​	400	​	​	(56)	​	​	344	​	1.75
Acquired customer lists	​	​	390	​	​	(358)	​	​	32	​	0.01
Total	​	$	94,220	​	$	(8,756)	​	$	85,464	​	13.47

​

​

Schedule of future amortization expense

​

​	​	​	​
​		March 31,
​	​	(In thousands)
2022 (remaining 3 months)	​	$	1,624
2023	​	​	6,490
2024	​	​	6,477
2025	​	​	6,282
2026	​	​	5,938
2027	​	​	5,908
Thereafter	​	​	39,109
Total future amortization expense	​	$	71,828

X

- References

No definition available.

+ Details

Name:	us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275

+ Details

Name:	us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267

+ Details

Name:	us-gaap_ScheduleOfGoodwillTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-Subparagraph (b),(d)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

+ Details

Name:	us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

+ Details

Name:	us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration